Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: Influence of anti-insulin antibodies

Diabetic Medicine

Volumn 13, Issue 12, 1996, Pages 1051-1055

  Lassmann Vague, V ^a   Belicar, P ^a   Alessis, C ^a   Raccah, D ^a   Vialettes, B ^a   Vague, P ^a  

^a TIMONE HOSPITAL   (France)

Author keywords

Free insulin; Insulin kinetics; Insulin treatment; Intraperitoneal insulin; Type 1 diabetes mellitus

Indexed keywords

INSULIN; INSULIN ANTIBODY;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL DRUG ADMINISTRATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INFUSIONS, PARENTERAL; INSULIN; INSULIN ANTIBODIES; INSULIN INFUSION SYSTEMS; KINETICS; MALE; PERITONEAL CAVITY;

EID: 0029681162     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9136(199612)13:12<1051::AID-DIA286>3.0.CO;2-Y     Document Type: Article

References (26)

1. Stolar MW. Atherosclerosis in diabetes : the role of hyperinsulinemia. Metabolism 1988; 37: 1-3.
2. Nelson JA, Stephen R, Landau ST, Wilson DE, Tyler FH. Intraperitoneal insulin administration produces a positive portal-systemic blood insulin gradient in unanesthetized unrestrained swine. Metabolism 1982; 31: 969-972.
3. Shade DS, Eaton RP, Davis T, Akiya F, Phinney E, Kubica R, et al. The kinetics of peritoneal insulin absorption. Metabolism 1981; 30: 149-155.
4. Selam JL, Bergman RN, Raccah D, Jeandidier N, Lozano J, Charles MA. Determination of portal insulin absorption from the peritoneum via a novel non isotopic method. Diabetes 1990; 39: 1361-1365.
5. Giacca A, Caumo A, Galimberti G, Petrella G, Librenti MC, Scavini M, et al. Peritoneal and subcutaneous absorption of insulin in type I diabetic subjects. J Clin Endocrinol Metab 1993; 77: 738-742.
6. Stevenson RW, Parsons JA, Alberti KGMM. Comparison of the metabolic responses to portal and peripheral infusions of insulin in diabetic dogs. Metabolism 1981; 30: 745-752.
7. Selam JL, Raymond M, Jacquemin JL, Orsetti A, Richard JL, Mirouze J. Pharmacokinetics of insulin infused intraperitoneally via portable pumps. Diabète Métab 1985; 11: 170-173.
8. Shade DS, Eaton RP, Friedman NM, Spencer WJ. Normalization of plasma insulin profiles with intraperitoneal insulin infusion in diabetic man. Diabetologia 1980; 19: 35-39.
9. Jimenez JT, Walford S, Home PD, Hanning J, Alberti KGMM. Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients. Diabetologia 1985; 28: 728-733.
10. Wredling R, Liu D, Lins PE, Adamson U. Variation of insulin absorption during subcutaneous and peritoneal infusion in insulin-dependent diabetic patients with unsatisfactory long-term glycaemic response to continuous subcutaneous insulin infusion. Diabète Metab 1991; 17: 456-459.
11. Scavini M, Pincelli Al, Cruciani C, Giberti B, Orsi E, Galimberti G, et al. Influence of meal ingestion on insulin profiles following intraperitoneal delivery. Metabolism 1993; 42: 1013-1016.
12. Micossi P, Bosi E, Cristallo M, Monti LD, Librenti MC, Petrella G, et al. Chronic continuous intraperitoneal insulin infusion (CIPII) in type I diabetic patients non-satisfactorily responsive to continuous subcutaneous insulin infusion (CSII). Acta Diabetol Lat 1986; 23: 155-164.
13. Ruotolo G, Micossi P, Galimberti G, Librenti MC, Petrella G, Marcovina S, et al. Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes. Metabolism 1990; 39: 598-604.
14. Selam JL, Kashyap M, Alberti KGMM, Lozano J, Hanna M, Turner D, et al. Comparison of intraperitoneal and subcutaneous insulin administration on lipids, apolipoproteins, fuel metabolites and hormones in type I diabetes mellitus. Metabolism 1989; 38: 908-912.
15. Olsen CL, Chan E, Turner DS, Iravani M, Nagy M, Selam JL, et al. Insulin antibody responses after long-term intraperitoneal insulin administration via implantable programmable insulin delivery systems. Diabetes Care 1994; 17: 169-176.
16. Jeandidier N, Boivin S, Sapin R, Rosart-Ortega F, Ming-Lambert B, Réville Ph, Pinget M. Immunogenicity of intraperitoneal insulin infusion using programmable implantabledevices. Diabetologie 1995; 38: 577-584.
17. Lassmann-Vague V, Belicar P, Raccah D, Vialettes B, Sodoyez JC, Vague Ph. Immunogenecity of long-term intraperitoneal insulin administration with programmable pumps: metabolic consequences. Diabetes Care 1995; 18: 498-503.
18. Nakagawa S, Nakayama H, Sasaki T, Yoshino K, Yu YY, Shinozaki K, et al. A simple method of the determination of serum free insulin levels in insulin-treated patients. Diabetes 1973; 22: 530-600.
19. Point Study Group. One-year trial of a remote-controlled implantable infusion system in type I diabetic patients. Lancet 1988; 866-869.
20. Saudek CD, Selam JL, Pitt HA, Waxman K, Rubio M, Jeandidier N, et al. A preliminary trial of the programmable implantable medication system for insulin delivery. N Engl J Med 1989; 321: 574-579.
21. Hanaire-Broutin H, Broussole C, Jeandidier N, Renard E, Guerci B, Haardt MJ, Lassmann-Vague V., for the EVADIAC Study Group. Intraperitoneal insulin therapy with programmable implantable pumps in insulin dependent diabetes : The trench multicenter study. Diabetes Care 1995; 18: 388-392.
22. Broussole C, Jeandidier N, Hanaire-Broutin H, for the EVADIAC Study Group. French multicentre experience of implantable insulin pumps. Lancet 1994; 343: 514-515.
23. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
24. Van Haeften TW, Heiling VJ, Gerich JE. Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance. Implications for intensive insulin regimens. Diabetes 1987; 36: 305-309.
25. Gardner DF, Wilson HK, Podet EJ, Arakaki RF, Nell LJ, Thomas JW, et al. Prolonged action of regular insulin in diabetic patients : lack of relationship to circulating insulin antibodies. J Clin Endocrinol Metabol 1986; 62: 621-627.
26. De Meijer PHEM, Lutterman JA, Van't Laar A. Insulin antibodies do not influence the absorption rate of subcutaneously injected insulin. Diabetic Med 1988; 5: 776-781.